Gaining patients'consent to enter clinical trials is essential, but not easy.
Giving careful thought to the design of the study itself, information which patients receive, and the use of a signed consent form may all help.
To be properly informed, patients need to know something about their condition, the proposed study, and alternative options.
The type and amount of information will vary and investigators need to judge the level appropriate for each person.
Patients should understand that taking part in a clinical trial is voluntary and that their decision will not affect the quality of care they receive.
The process of obtaining consent requires time and good communication.
Working with young, elderly, or mentally impaired patients, or those particularly vulnerable to coercion, requires special sensitivity to the potential dangers.
Mots-clés Pascal : Traitement, Homme, Consentement éclairé, Essai clinique, Ethique
Mots-clés Pascal anglais : Treatment, Human, Informed consent, Clinical trial, Ethics
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0560017
Code Inist : 002B30A09. Création : 01/03/1996.